Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Cash flows from operating activities:
Net income	$ 11,530	$ 14,322
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	9,189	9,268
Amortization of debt issuance costs	104	84
Provision for doubtful accounts	1,976	632
Share-based compensation	1,255	1,391
Deferred income taxes	(226)	397
Change in fair value of contingent consideration	2,472	4,584
Contingent consideration payments excess	0	(2,089)
Finance lease interest	22	0
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable	(60,710)	(398)
Inventories	(26,069)	(78,828)
Prepaid expenses and other assets	807	(4,320)
Other non-current assets	(6,947)	124
Accounts payable	101,496	69,073
Accrued expenses and other liabilities	10,015	(4,115)
Income taxes payable	2,086	(4,411)
Net cash provided by operating activities	47,000	5,714
Cash flows from investing activities:
Capital expenditures	(940)	(990)
Cash paid for business acquisitions, net of cash acquired	(49,080)	(13,207)
Net cash used in investing activities	(50,020)	(14,197)
Cash flows from financing activities:
Borrowings on revolving credit	537,926	559,911
Repayments on revolving credit	(520,139)	(527,151)
Repayments on short-term borrowings, net	(4,527)	0
Repayments on long-term debt	(1,272)	(330)
Repayments of finance lease obligations	(391)
Repayments of finance lease obligations		165
Contingent consideration payments	0	(30,158)
Exercise and issuance of equity awards	0	440
Taxes paid on settlement of equity awards	(12)	(15)
Repurchase of common stock	(6,077)	0
Net cash provided by financing activities	5,508	2,532
Effect of exchange rate changes on cash and cash equivalents	(429)	(721)
Increase (decrease) in cash and cash equivalents	2,059	(6,672)
Cash and cash equivalents at beginning of period	23,818	25,530
Cash and cash equivalents at end of period	$ 25,877	$ 18,858